CNS Pharmaceuticals (CNSP) Institutional Ownership → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free CNSP Stock Alerts $0.20 0.00 (0.00%) (As of 04/19/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for CNS Pharmaceuticals (NASDAQ:CNSP)CurrentInstitutional OwnershipPercentage14.02%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$461.62KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$9.23K Get CNSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNSP Institutional Buying and Selling by Quarter Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! CNS Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails3/11/2024Vanguard Group Inc.58,369$74K0.0%+145.6%0.940% 2/13/2024Armistice Capital LLC122,000$155K0.0%N/A1.965% 1/17/2024Smith Anglin Financial LLC50,000$64K0.0%N/A0.952% 8/14/2023State Street Corp22,556$50K0.0%N/A1.011% 8/11/2023Geode Capital Management LLC16,142$36K0.0%N/A0.724% 8/7/2023Acadian Asset Management LLC22,292$49K0.0%N/A1.000% Get the Latest News and Ratings for CNSP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNS Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/12/2023FSM Wealth Advisors LLC16,334$38K0.0%N/A0.732% 5/16/2023Armistice Capital LLC124,000$124K0.0%-6.9%5.571% 5/12/2023Renaissance Technologies LLC26,800$27K0.0%N/A1.204% 2/15/2023Armistice Capital LLC133,229$320K0.0%N/A0.999% 8/13/2022Virtu Financial LLC178,184$50K0.0%+59.5%0.445% 5/17/2022Virtu Financial LLC111,749$38K0.0%N/A0.279% 5/13/2022Renaissance Technologies LLC506,532$173K0.0%+242.9%1.265% 5/13/2022Vanguard Group Inc.427,703$146K0.0%-29.8%1.068% 5/11/2022Bank of New York Mellon Corp234,892$80K0.0%+689.3%0.587% 9/17/2021Virtu Financial LLC20,745$41K0.0%-49.8%0.076% 8/13/2021Renaissance Technologies LLC432,109$847K0.0%-40.2%1.704% 8/13/2021Geode Capital Management LLC100,196$196K0.0%+64.8%0.395% 8/13/2021Vanguard Group Inc.599,309$1.18M0.0%+326.6%2.363% 8/11/2021Commonwealth Equity Services LLC20,000$39K0.0%N/A0.079% 5/19/2021Virtu Financial LLC41,310$99K0.0%N/A0.163% 5/18/2021Citadel Advisors LLC92,404$221K0.0%N/A0.364% 5/18/2021Jane Street Group LLC13,747$33K0.0%N/A0.054% 5/17/2021Goldman Sachs Group Inc.11,566$28K0.0%N/A0.046% 5/13/2021Renaissance Technologies LLC722,760$1.73M0.0%N/A2.850% 5/13/2021Bank of New York Mellon Corp43,659$104K0.0%N/A0.172% 5/12/2021Northern Trust Corp32,094$77K0.0%N/A0.127% 5/12/2021Geode Capital Management LLC60,784$145K0.0%N/A0.240% 2/16/2021Warberg Asset Management LLC14,000$25K0.0%N/A0.059% 11/12/2020Essex Investment Management Co. LLC61,563$108K0.0%-13.5%0.370% 5/4/2020Essex Investment Management Co. LLC71,494$150K0.0%-7.7%0.435% (Data available from 1/1/2016 forward) CNSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNSP shares? During the previous two years, 10 institutional investors and hedge funds held shares of CNS Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($155K), Bank of New York Mellon Corp ($80K), Vanguard Group Inc. ($74K), Smith Anglin Financial LLC ($64K), State Street Corp ($50K), Virtu Financial LLC ($50K), and Acadian Asset Management LLC ($49K).Learn more on CNSP's institutional investors. What percentage of CNS Pharmaceuticals stock is owned by institutional investors? 14.02% of CNS Pharmaceuticals stock is owned by institutional investors. Learn more on CNSP's institutional investor holdings. Which institutional investors have been buying CNS Pharmaceuticals stock? Of the 10 institutional investors that purchased CNS Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($385.63K), Armistice Capital LLC ($255.23K), Bank of New York Mellon Corp ($205.13K), Virtu Financial LLC ($178.18K), Smith Anglin Financial LLC ($50K), Vanguard Group Inc. ($34.60K), and State Street Corp ($22.56K). How much institutional buying is happening at CNS Pharmaceuticals? Institutional investors have bought a total of 1,186,107 shares in the last 24 months. This purchase volume represents approximately $8.25M in transactions. Which CNS Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold CNS Pharmaceuticals stock in the last 24 months: Vanguard Group Inc. ($181.71K), and Armistice Capital LLC ($9.23K). How much institutional selling is happening at CNS Pharmaceuticals? Institutional investors have sold a total of 190,935 shares in the last 24 months. This volume of shares sold represents approximately $1.87M in transactions. Related Companies: APVO Institutional Ownership NBSE Institutional Ownership SXTP Institutional Ownership PHIO Institutional Ownership BXRX Institutional Ownership GRI Institutional Ownership AMPE Institutional Ownership ADIL Institutional Ownership PBLA Institutional Ownership NEPT Institutional Ownership This page (NASDAQ:CNSP) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.